# KBI Biopharma, Inc. – FDA Inspection, Apr 1, 2026

Source: https://www.keypedia.com/records/fda_inspections/kbi-biopharma-inc/c23fd1bf-6113-4a1b-956d-885f190a4130
Source feed: FDA_Inspections

> FDA inspection 1312108 of KBI Biopharma, Inc., April 01, 2026. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1312108
- Company Name: KBI Biopharma, Inc.
- Inspection Date: 2026-04-01
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1241524 - 2024-06-18](https://www.keypedia.com/records/fda_inspections/kbi-biopharma-inc/5cd2e622-d49c-44b5-b6e3-44ca23f7bcc6)
- FDA Inspection 1051652 - 2018-04-11
- FDA Inspection 937768 - 2015-07-16
- FDA Inspection 796226 - 2012-08-29
- FDA Inspection 625271 - 2009-10-09

## Related Officers

- [Company Rep](https://www.keypedia.com/people/marian-e-ramirez/4b718b67-fee0-488c-9354-ee366d3510ad)
- [Issuing Officer](https://www.keypedia.com/people/yoriann-m-cabrera-bartolomei/3f827fbc-dcd1-4698-9bae-e0e93b900d08)

Company: https://www.keypedia.com/companies/kbi-biopharma-inc/c19eb9d6-d05c-437c-b018-992dba71d288

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7